Precision BioSciences
DTIL · NASDAQ
$6.56+$0.37 (+5.98%)TodayMarket closed ·
Prev close $6.19
EPS: actual vs estimate
Beat the estimate in 1 of the last 8 quarters, by 292.4% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.8058 | -$1.26 | −56.4% |
| Q1 FY26 | -$0.6681 | -$0.75 | −12.3% |
| Q4 FY25 | -$0.5457 | $1.05 | +292.4% |
| Q3 FY25 | -$1.37 | -$1.84 | −34.6% |
| Q2 FY25 | -$1.60 | -$2.13 | −33.3% |
| Q1 FY25 | -$1.75 | -$2.21 | −26.2% |
| Q4 FY24 | -$2.00 | -$2.22 | −10.9% |
| Q3 FY24 | -$1.96 | -$2.25 | −14.7% |
Earnings calls
- Special Call - Precision BioSciences, Inc.
- 25th Annual Needham Virtual Healthcare Conference
- Shareholder/Analyst Call - Precision BioSciences, Inc.
- Special Call - Precision BioSciences, Inc.
- H.C. Wainwright 27th Annual Global Investment Conference
- Special Call - Precision BioSciences, Inc.
- Jones Healthcare and Technology Innovation Conference 2025
- 24th Annual Needham Virtual Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.